UnitedHealth (UNH) reported Q1 FY2023 earnings of $6.26 per share (versus $5.49 per share in Q1 FY2022), beating analysts’ consensus estimate of $6.08 per share.
The company’s quarterly revenues amounted to $91.931 bln (+14.7% y/y), beating analysts’ consensus estimate of $89.767 bln.
The company also raised its FY2023 EPS guidance to $24.50-25.00, up from prior guidance of $24.40-24.90, versus analysts’ consensus estimate of $24.93.
UNH rose to $534.00 (+1.48%) in pre-market trading.
